Invesaro

Stocks Comparison

Davita vs Marpai: revenue, profit, margins and growth compared

Davita brought in $13.6B of revenue in fiscal 2025, Marpai $18.1M in fiscal 2025. Revenue changed by +6.5% at Davita and -35.8% at Marpai on the year before, so Davita grew faster. Davita kept 5.5% of its revenue as net profit, Marpai -91.5%.

Side by side, latest fiscal year

DVAMRAI
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$13.6B$18.1M
Revenue growth+6.5%-35.8%
Net income$746.8M-$16.6M
Net margin5.5%-91.5%
Free cash flow$1.3Bn/a
Free cash flow margin9.6%n/a
Earnings per share (diluted)$9.84-$0.95
Cash$676.4M$133K
Debt$10.3B$19.4M
Price to earnings18.2n/a
Market value$11.4B$91M
Dividend yieldn/an/a
Rank by revenue in sector#38 of 742 · Health care#481 of 742 · Health care

Over the years

Revenue
DVA FY2018: $11.4BDVA FY2019: $11.4BDVA FY2020: $11.6BDVA FY2021: $11.6BDVA FY2022: $11.6BDVA FY2023: $12.1BDVA FY2024: $12.8BDVA FY2025: $13.6BMRAI FY2021: $14.2MMRAI FY2022: $24.3MMRAI FY2023: $37.2MMRAI FY2024: $28.2MMRAI FY2025: $18.1MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $13.6BMRAI $18.1M
Net income
DVA FY2018: $159.4MDVA FY2019: $811MDVA FY2020: $773.6MDVA FY2021: $978.5MDVA FY2022: $560.4MDVA FY2023: $691.5MDVA FY2024: $936.3MDVA FY2025: $746.8MMRAI FY2021: -$3.9MMRAI FY2021: -$16MMRAI FY2022: -$26.5MMRAI FY2023: -$28.8MMRAI FY2024: -$22.1MMRAI FY2025: -$16.6MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $746.8MMRAI -$16.6M
Net margin
DVA FY2018: 1.4%DVA FY2019: 7.1%DVA FY2020: 6.7%DVA FY2021: 8.4%DVA FY2022: 4.8%DVA FY2023: 5.7%DVA FY2024: 7.3%DVA FY2025: 5.5%MRAI FY2021: -112.4%MRAI FY2022: -108.7%MRAI FY2023: -77.4%MRAI FY2024: -78.4%MRAI FY2025: -91.5%FY18FY19FY20FY21FY22FY23FY24FY25
DVA 5.5%MRAI -91.5%
Revenue growth
DVA FY2019: -0.1%DVA FY2020: +1.4%DVA FY2021: +0.6%DVA FY2022: -0.1%DVA FY2023: +4.6%DVA FY2024: +5.6%DVA FY2025: +6.5%MRAI FY2022: +71.1%MRAI FY2023: +52.6%MRAI FY2024: -24.2%MRAI FY2025: -35.8%FY19FY20FY21FY22FY23FY24FY25
DVA +6.5%MRAI -35.8%
Free cash flow
DVA FY2018: $784.5MDVA FY2019: $1.3BDVA FY2020: $1.3BDVA FY2021: $1.3BDVA FY2022: $961.1MDVA FY2023: $1.5BDVA FY2024: $1.5BDVA FY2025: $1.3BMRAI FY2021: -$2MMRAI FY2021: -$11.1MMRAI FY2022: -$35.6MFY18FY19FY20FY21FY22FY23FY24FY25
DVA $1.3BMRAI -$35.6M

Fiscal years as each company reports them; the two may end in different months.

Questions about Davita and Marpai

Which is bigger by revenue, Davita or Marpai?

Davita is bigger by revenue: $13.6B in fiscal 2025, against $18.1M for Marpai in fiscal 2025.

Which keeps more of its revenue as profit, Davita or Marpai?

Davita had a net margin of 5.5% in fiscal 2025; Marpai had -91.5% in fiscal 2025.

Which grew revenue faster, Davita or Marpai?

In their latest fiscal years revenue changed by +6.5% at Davita and -35.8% at Marpai.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies